Ars Technica - All content

Official app was a disaster, so knowledgeable parents built an open source alternative.

It’s not enough to drastically slash emissions—we need more carbon capture.

The widow learned of the dissection from a news reporter.

Productivity-focused mouse offers advanced features in a portable size.

Some future Mac chips will have two dies instead of one.

About 50 titles are affected, though there are workarounds and pending fixes.

Airflow, RGB, transparency are good ideas—but they're in need of better execution.

T2 bug "prevented a very small number of users from booting" after updating.

Exploring the DDR5 tax, small-form-factor builds, stock issues, and more.

SpaceX provides encouraging update, but preorderers still see 2023 delivery dates.

Not many zombies, but loads of Wagner and the return of our fave goofy nerd Ludwig Dieter.

Humans are at least 68 percent responsible for the wildfires in the Western US.

Prosecution dealt setback as judge rules patient can’t testify.

The Pixel Foldable is getting a camera downgrade, but that's normal for foldables.

Upping the ante with longer battery life and a wrist rest.

The oral COVID-19 drug is the second to produce promising trial results.

But fossil fuel emissions alone are still ticking upward.

Isomorphic Labs will build on DeepMind’s research and will be headed by Demis Hassabis.

Laura Schwab was sales and marketing VP at the startup until last month.

Released to coincide with COP26, it's meant to illustrate impact of climate change.

Dealmaster has a few favorite wearables and wireless headphones at low prices.

"Our mission is to provide people with the choice of what we view as the best."

The decadal survey is a highly influential 10-year plan for what should come next.

Execs see promise for tracking in-game collectibles and "play-to-earn" schemes.

Blue Origin’s Moon landing dreams derailed in one-page ruling.

Scientists also identified bird egg proteins in sample, most likely from Muscovy duck.

Smartmatic machines didn't actually switch Trump votes to Biden, lawsuits note.

Some issues have already been addressed, others are waiting for a fix.

Homeopathic treatments are placebos at best and will not protect from COVID-19.

Human drivers will take Waymo cars around NYC for mapping and winter experience.

Attorney said he trusted Theranos documents, including fake Pfizer report.

The concept will be revealed this month, the production car is due in 2024.

Asus' Windows 11-based convertible will start at $600 in December.

Intel's power-gulping i9-12900K crushes AMD's Ryzen 9 5950x—even multithreaded.

Horizon remains the best open-world racing series. Five games in, is that enough?

The concept rides the recent "metaverse" hype, but it's only a precursor.

FCC approves 147-satellite plan without adding conditions requested by SpaceX.

Meanwhile, vaccine mandates continue to prove effective in other states.

First small-scale demonstration of a full-stack production line.

Electrification is coming to the aftermarket, too, as evinced by this year's show.

NSO Group added to Entity List to stem spread of "digital tools used for repression."

Two-factor authentication is coming to Google accounts whether you want it or not.

Investors tell jury that they believed pharma companies had validated the tech.

CEO says staff is seeing "increased competition... and higher voluntary turnover."

HBO Max's new series is adapted from the bestselling novel by Emily St. John Mandel.

"Any sensor, any shooter" means more fighting flexibility—and more complexity.

Unwieldy, promising film would have been an epic TV series. Alas.

With CDC director's sign off, vaccination of children can now begin.

Lots of sulfuric volatiles in saliva correlated with kids' dislike of these veggies.

Regulatory pressure and massive lawsuits may have forced its hand.